Comparison of automatic methods MALDI-TOF, VITEK2 and manual methods for the identification of intestinal microbial communities on the example of samples from alpacas (<i>Vicugna pacos</i>)

Pławińska-Czarnak, Joanna; Wódz, Karolina; Strzałkowska, Zuzanna; Żychska, Monika; Nowak, Tomasz; Kwieciński, Adam; Kwieciński, Piotr; Bielecki, Wojciech; Rodo, Anna; Rzewuska, Magdalena; Kłosińska, Daria; Anusz, Krzysztof; Orłowska, Blanka

doi:10.2478/jvetres-2023-0051

Cited by 2 publications

(1 citation statement)

References 29 publications

(45 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, in 2013, S. ciferrii was isolated on the skin and mucous membranes of English full-blood mares, indicating that these yeasts could be part of the cutaneous microbiota of horses [131]. The latest data regarding the isolation of C. ciferrii from animals and the environment document the presence of C. ciferrii in the gastrointestinal tract of alpacas in Poland [132] (Figure 7). Environmental isolates of the S. ciferrii complex are found worldwide, suggesting that this fungus may be an inhabitant of the soil and marine aquatic environments [133].…”

Section: S Ciferrii Complex In the One Health Perspectivementioning

confidence: 99%

Stephanoascus ciferrii Complex: The Current State of Infections and Drug Resistance in Humans

Cosio,

Pica,

Fontana

et al. 2024

JoF

View full text Add to dashboard Cite

In recent years, the incidence of fungal infections in humans has increased dramatically, accompanied by an expansion in the number of species implicated as etiological agents, especially environmental fungi never involved before in human infection. Among fungal pathogens, Candida species are the most common opportunistic fungi that can cause local and systemic infections, especially in immunocompromised individuals. Candida albicans (C. albicans) is the most common causative agent of mucosal and healthcare-associated systemic infections. However, during recent decades, there has been a worrying increase in the number of emerging multi-drug-resistant non-albicans Candida (NAC) species, i.e., C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, C. auris, and C. ciferrii. In particular, Candida ciferrii, also known as Stephanoascus ciferrii or Trichomonascus ciferrii, is a heterothallic ascomycete yeast-like fungus that has received attention in recent decades as a cause of local and systemic fungal diseases. Today, the new definition of the S. ciferrii complex, which consists of S. ciferrii, Candida allociferrii, and Candida mucifera, was proposed after sequencing the 18S rRNA gene. Currently, the S. ciferrii complex is mostly associated with non-severe ear and eye infections, although a few cases of severe candidemia have been reported in immunocompromised individuals. Low susceptibility to currently available antifungal drugs is a rising concern, especially in NAC species. In this regard, a high rate of resistance to azoles and more recently also to echinocandins has emerged in the S. ciferrii complex. This review focuses on epidemiological, biological, and clinical aspects of the S. ciferrii complex, including its pathogenicity and drug resistance.

show abstract

Section: S Ciferrii Complex In the One Health Perspectivementioning

confidence: 99%